Peter Gennemark

1.8k total citations
55 papers, 1.2k citations indexed

About

Peter Gennemark is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Peter Gennemark has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 10 papers in Physiology and 9 papers in Surgery. Recurrent topics in Peter Gennemark's work include Gene Regulatory Network Analysis (12 papers), Microbial Metabolic Engineering and Bioproduction (10 papers) and Adipose Tissue and Metabolism (8 papers). Peter Gennemark is often cited by papers focused on Gene Regulatory Network Analysis (12 papers), Microbial Metabolic Engineering and Bioproduction (10 papers) and Adipose Tissue and Metabolism (8 papers). Peter Gennemark collaborates with scholars based in Sweden, United Kingdom and United States. Peter Gennemark's co-authors include Bodil Nordlander, Stefan Hohmann, Edda Klipp, Dag Wedelin, Sven Nelander, Chris Sander, Qing‐Bai She, Weiqing Wang, Neal Rosen and Christine A. Pratilas and has published in prestigious journals such as Blood, Nature Biotechnology and Bioinformatics.

In The Last Decade

Peter Gennemark

52 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Gennemark Sweden 15 714 146 118 109 101 55 1.2k
Yiping Wang China 25 756 1.1× 68 0.5× 137 1.2× 32 0.3× 74 0.7× 70 1.6k
Andrew R. Harper United Kingdom 15 363 0.5× 62 0.4× 177 1.5× 38 0.3× 90 0.9× 41 939
David Friedecký Czechia 21 632 0.9× 155 1.1× 47 0.4× 16 0.1× 93 0.9× 113 1.3k
Yiliang Chen United States 23 772 1.1× 147 1.0× 131 1.1× 59 0.5× 196 1.9× 81 1.6k
Randy Nelson Canada 15 551 0.8× 184 1.3× 51 0.4× 38 0.3× 260 2.6× 25 1.2k
Liqian Chen China 15 599 0.8× 57 0.4× 159 1.3× 57 0.5× 38 0.4× 69 1.1k
Shinya Nakamura Japan 19 913 1.3× 39 0.3× 127 1.1× 66 0.6× 46 0.5× 67 1.7k
Jane P. F. Bai United States 25 553 0.8× 78 0.5× 59 0.5× 236 2.2× 45 0.4× 72 1.4k

Countries citing papers authored by Peter Gennemark

Since Specialization
Citations

This map shows the geographic impact of Peter Gennemark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Gennemark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Gennemark more than expected).

Fields of papers citing papers by Peter Gennemark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Gennemark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Gennemark. The network helps show where Peter Gennemark may publish in the future.

Co-authorship network of co-authors of Peter Gennemark

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Gennemark. A scholar is included among the top collaborators of Peter Gennemark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Gennemark. Peter Gennemark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nyman, Elin, Peter Gennemark, Peter Gustafsson, et al.. (2024). A unified framework for prediction of liver steatosis dynamics in response to different diet and drug interventions. Clinical Nutrition. 43(6). 1532–1543. 1 indexed citations
2.
Kanebratt, Kajsa P., Charlotte Wennberg Huldt, Lisa U. Magnusson, et al.. (2024). Normoglycemia and physiological cortisone level maintain glucose homeostasis in a pancreas-liver microphysiological system. Communications Biology. 7(1). 877–877. 4 indexed citations
3.
Ekstedt, Mattias, Peter Lundberg, Karin G. Stenkula, et al.. (2023). A multi-scale digital twin for adiposity-driven insulin resistance in humans: diet and drug effects. Diabetology & Metabolic Syndrome. 15(1). 250–250. 7 indexed citations
4.
Gennemark, Peter, Nigel Davies, Marie Elebring, et al.. (2023). Injectable Biodegradable Silica Depot for Controlled Subcutaneous Delivery of Antisense Oligonucleotides with beyond Monthly Administration. Molecular Pharmaceutics. 21(1). 143–151.
5.
Antonsson, Madeleine, et al.. (2023). Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs). Clinical Pharmacokinetics. 62(12). 1661–1672. 6 indexed citations
6.
Boianelli, Alessandro, et al.. (2022). Cross-Species Translation of Biophase Half-Life and Potency of GalNAc-Conjugated siRNAs. Nucleic Acid Therapeutics. 32(6). 507–512. 12 indexed citations
7.
Ekstedt, Mattias, et al.. (2022). Digital twin predicting diet response before and after long-term fasting. PLoS Computational Biology. 18(9). e1010469–e1010469. 14 indexed citations
8.
Bauer, Sophie, Kajsa P. Kanebratt, Charlotte Wennberg Huldt, et al.. (2022). Integrated experimental-computational analysis of a HepaRG liver-islet microphysiological system for human-centric diabetes research. PLoS Computational Biology. 18(10). e1010587–e1010587. 6 indexed citations
9.
Weidolf, Lars, Anders Björkbom, Anders Dahlén, et al.. (2021). Distribution and biotransformation of therapeutic antisense oligonucleotides and conjugates. Drug Discovery Today. 26(10). 2244–2258. 20 indexed citations
10.
Tyrberg, Björn, Charlotte Wennberg Huldt, Peter Gennemark, et al.. (2020). Inhibition of the prostaglandin D2–GPR44/DP2 axis improves human islet survival and function. Diabetologia. 63(7). 1355–1367. 13 indexed citations
11.
Jansson‐Löfmark, Rasmus, Christine Ahlström, & Peter Gennemark. (2019). ADME: Assessing Pharmacokinetic–Pharmacodynamic Parameters of Oligonucleotides. Methods in molecular biology. 2036. 317–339. 1 indexed citations
12.
Jansson‐Löfmark, Rasmus & Peter Gennemark. (2018). Inferring Half-Lives at the Effect Site of Oligonucleotide Drugs. Nucleic Acid Therapeutics. 28(6). 319–325. 11 indexed citations
13.
Chappell, Michael J., et al.. (2017). Input Estimation for Extended-Release Formulations Exemplified with Exenatide. Frontiers in Bioengineering and Biotechnology. 5. 24–24. 3 indexed citations
14.
Aoki, Yasunori, Monika Sundqvist, Andrew C. Hooker, & Peter Gennemark. (2016). PopED lite: An optimal design software for preclinical pharmacokinetic and pharmacodynamic studies. Computer Methods and Programs in Biomedicine. 127. 126–143. 6 indexed citations
15.
Nyman, Elin, Gabriel Helmlinger, Bengt Hamrén, et al.. (2016). Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes. Interface Focus. 6(2). 20150075–20150075. 19 indexed citations
16.
Davidsson, Pia, et al.. (2015). Studies of Nontarget-Mediated Distribution of Human Full-Length IgG1 Antibody and Its FAb Fragment in Cardiovascular and Metabolic-Related Tissues. Journal of Pharmaceutical Sciences. 104(5). 1825–1831. 3 indexed citations
17.
Gennemark, Peter, et al.. (2013). Population pharmacokinetic modeling and deconvolution of enantioselective absorption of eflornithine in the rat. Journal of Pharmacokinetics and Pharmacodynamics. 40(1). 117–128. 11 indexed citations
18.
Gennemark, Peter & Dag Wedelin. (2013). ODEion — A SOFTWARE MODULE FOR STRUCTURAL IDENTIFICATION OF ORDINARY DIFFERENTIAL EQUATIONS. Journal of Bioinformatics and Computational Biology. 12(1). 1350015–1350015. 4 indexed citations
19.
Gennemark, Peter. (2005). Modeling and identification of biological systems with emphasis on osmoregulation in yeast. Chalmers Publication Library (Chalmers University of Technology).
20.
Klipp, Edda, et al.. (2005). Integrative model of the response of yeast to osmotic shock. Nature Biotechnology. 23(8). 975–982. 319 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiping Wang Breakdown of academic impact, for papers by Andrew R. Harper Breakdown of academic impact, for papers by David Friedecký Breakdown of academic impact, for papers by Yiliang Chen Breakdown of academic impact, for papers by Randy Nelson Breakdown of academic impact, for papers by Liqian Chen Breakdown of academic impact, for papers by Shinya Nakamura Breakdown of academic impact, for papers by Jane P. F. Bai
Rankless by CCL
2026